Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q79828937)
Watch
English
Monitoring of minimal residual disease in acute myeloid leukemia
scientific article published on 01 January 2008
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
18000811
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18000811%20AND%20SRC:MED&resulttype=core&format=json
retrieved
26 December 2019
review article
1 reference
stated in
Europe PubMed Central
title
Monitoring of minimal residual disease in acute myeloid leukemia
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
18000811
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18000811%20AND%20SRC:MED&resulttype=core&format=json
retrieved
26 December 2019
main subject
acute myeloid leukemia
1 reference
based on heuristic
inferred from title
author name string
Wolfgang Kern
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
18000811
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18000811%20AND%20SRC:MED&resulttype=core&format=json
retrieved
26 December 2019
Claudia Haferlach
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
18000811
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18000811%20AND%20SRC:MED&resulttype=core&format=json
retrieved
26 December 2019
Torsten Haferlach
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed publication ID
18000811
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18000811%20AND%20SRC:MED&resulttype=core&format=json
retrieved
26 December 2019
Susanne Schnittger
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed publication ID
18000811
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18000811%20AND%20SRC:MED&resulttype=core&format=json
retrieved
26 December 2019
publication date
1 January 2008
1 reference
stated in
Europe PubMed Central
PubMed publication ID
18000811
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18000811%20AND%20SRC:MED&resulttype=core&format=json
retrieved
26 December 2019
number of pages
13
1 reference
based on heuristic
inferred from page(s)
published in
Cancer
1 reference
stated in
Europe PubMed Central
PubMed publication ID
18000811
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18000811%20AND%20SRC:MED&resulttype=core&format=json
retrieved
26 December 2019
volume
112
1 reference
stated in
Europe PubMed Central
PubMed publication ID
18000811
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18000811%20AND%20SRC:MED&resulttype=core&format=json
retrieved
26 December 2019
issue
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
18000811
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18000811%20AND%20SRC:MED&resulttype=core&format=json
retrieved
26 December 2019
page(s)
4-16
1 reference
stated in
Europe PubMed Central
PubMed publication ID
18000811
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18000811%20AND%20SRC:MED&resulttype=core&format=json
retrieved
26 December 2019
cites work
Acute myeloid leukaemia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.23128
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.23128
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Monitoring of acute myeloid leukemia by flow cytometry
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.23128
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Monitoring of minimal residual disease in acute myeloid leukemia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.23128
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Early immunophenotypical evaluation of minimal residual disease in acute myeloid leukemia identifies different patient risk groups and may contribute to postinduction treatment stratification
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.23128
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Determination of relapse risk based on assessment of minimal residual disease during complete remission by multiparameter flow cytometry in unselected patients with acute myeloid leukemia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.23128
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Karyotype instability between diagnosis and relapse in 117 patients with acute myeloid leukemia: implications for resistance against therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.23128
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Shift of aberrant antigen expression at relapse or at treatment failure in acute leukemia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.23128
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phenotypic changes in acute myeloid leukaemia: implications in the detection of minimal residual disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.23128
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Stability of leukemia-associated aberrant immunophenotypes in patients with acute myeloid leukemia between diagnosis and relapse: comparison with cytomorphologic, cytogenetic, and molecular genetic findings
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.23128
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Detection of minimal residual disease in acute leukemia by flow cytometry
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.23128
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pretransplant minimal residual disease level predicts clinical outcome in patients with acute myeloid leukemia receiving high-dose chemotherapy and autologous stem cell transplantation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.23128
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Flow cytometric assessment of CD15+CD117+ cells for the detection of minimal residual disease in adult acute myeloid leukaemia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.23128
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinical significance of residual disease during treatment in childhood acute myeloid leukaemia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.23128
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Early blast clearance by remission induction therapy is a major independent prognostic factor for both achievement of complete remission and long-term outcome in acute myeloid leukemia: data from the German AML Cooperative Group (AMLCG) 1992 Trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.23128
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clearance of leukaemic blasts from peripheral blood during standard induction treatment predicts the bone marrow response in acute myeloid leukaemia: a pilot study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.23128
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The kinetics of reduction of minimal residual disease impacts on duration of response and survival of patients with acute myeloid leukemia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.23128
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Immunologic purging of autologous peripheral blood stem cell products based on CD34 and CD133 expression can be effectively and safely applied in half of the acute myeloid leukemia patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.23128
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Immunophenotypic evidence of leukemia after induction therapy predicts relapse: results from a prospective Children's Cancer Group study of 252 patients with acute myeloid leukemia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.23128
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
BIOMED-1 concerted action report: flow cytometric immunophenotyping of precursor B-ALL with standardized triple-stainings
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.23128
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Four-fold staining including CD45 gating improves the sensitivity of multiparameter flow cytometric assessment of minimal residual disease in patients with acute myeloid leukemia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.23128
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Residual disease detection using fluorescent polymerase chain reaction at 20 weeks of therapy predicts clinical outcome in childhood acute lymphoblastic leukemia.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.23128
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Quantitative nested reverse transcriptase PCR vs. real-time PCR for measuring AML1/ETO (MTG8) transcripts
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.23128
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Monitoring of minimal residual disease (MRD) by real-time quantitative reverse transcription PCR (RQ-RT-PCR) in childhood acute myeloid leukemia with AML1/ETO rearrangement
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.23128
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prognostic value of real-time quantitative PCR (RQ-PCR) in AML with t(8;21).
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.23128
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prognostic value of minimal residual disease (MRD) in acute myeloid leukemia (AML) with favorable cytogenetics [t(8;21) and inv(16)].
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.23128
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Minimal residual core binding factor AMLs by real time quantitative PCR--initial response to chemotherapy predicts event free survival and close monitoring of peripheral blood unravels the kinetics of relapse.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.23128
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
New score predicting for prognosis in PML-RARA+, AML1-ETO+, or CBFBMYH11+ acute myeloid leukemia based on quantification of fusion transcripts.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.23128
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Quantification of CBFbeta/MYH11 fusion transcript by real time RT-PCR in patients with INV(16) acute myeloid leukemia.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.23128
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The use of housekeeping genes for real-time PCR-based quantification of fusion gene transcripts in acute myeloid leukemia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.23128
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - a Europe Against Cancer program.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.23128
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Quantitative real-time RT-PCR analysis of PML-RAR alpha mRNA in acute promyelocytic leukemia: assessment of prognostic significance in adult patients from intergroup protocol 0129.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.23128
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinical importance of cytogenetics in acute myeloid leukaemia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.23128
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A randomized study with or without intensified maintenance chemotherapy in patients with acute promyelocytic leukemia who have become negative for PML-RARalpha transcript after consolidation therapy: the Japan Adult Leukemia Study Group (JALSG) APL9
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.23128
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Real-time quantitation of minimal residual disease in inv(16)-positive acute myeloid leukemia may indicate risk for clinical relapse and may identify patients in a curable state
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.23128
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Assessment of minimal residual disease (MRD) in CBFbeta/MYH11-positive acute myeloid leukemias by qualitative and quantitative RT-PCR amplification of fusion transcripts
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.23128
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Quantitation of minimal residual disease in acute promyelocytic leukemia patients with t(15;17) translocation using real-time RT-PCR
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.23128
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Development of a real‐time RT‐PCR assay for the quantification of the most frequent MLL/AF9 fusion types resulting from translocation t(9;11)(p22;q23) in acute myeloid leukemia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.23128
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A real-time quantitative RT-PCR assay for monitoring DEK-CAN fusion transcripts arising from translocation t(6;9) in acute myeloid leukemia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.23128
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.23128
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Screening for MLL tandem duplication in 387 unselected patients with AML identify a prognostically unfavorable subset of AML
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.23128
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Favorable prognostic significance of CEBPA mutations in patients with de novo acute myeloid leukemia: a study from the Acute Leukemia French Association (ALFA)
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.23128
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Nucleophosmin gene mutations are predictors of favorable prognosis in acute myelogenous leukemia with a normal karyotype
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.23128
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
FLT3 length mutations as marker for follow-up studies in acute myeloid leukaemia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.23128
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
FLT3 and MLL intragenic abnormalities in AML reflect a common category of genotoxic stress
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.23128
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.23128
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.23128
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Quantitative assessment of minimal residual disease in acute myeloid leukemia carrying nucleophosmin (NPM1) gene mutations.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.23128
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
AML patients with CEBPalpha mutations mostly retain identical mutant patterns but frequently change in allelic distribution at relapse: a comparative analysis on paired diagnosis and relapse samples
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.23128
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Fluorescent 5'-exonuclease assay for the absolute quantification of Wilms' tumour gene (WT1) mRNA: implications for monitoring human leukaemias
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.23128
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prognostic impact of RT-PCR-based quantification of WT1 gene expression during MRD monitoring of acute myeloid leukemia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.23128
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
High WT1 expression after induction therapy predicts high risk of relapse and death in pediatric acute myeloid leukemia.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.23128
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
EVI1 expression in acute myeloid leukaemia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.23128
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The EVI1 gene in myeloid leukemia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.23128
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Reverse transcriptase-polymerase chain reaction based quantification of the combined MDS-EVI1/EVI1 gene in acute myeloid leukemia.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.23128
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
PRAME mRNA levels in cases with acute leukemia: clinical importance and future prospects
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.23128
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Real-time RT-PCR quantification of PRAME gene expression for monitoring minimal residual disease in acute myeloblastic leukaemia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.23128
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Acute myeloid leukemia (AML) with t(8;21)(q22;q22) relapsing as AML with t(3;21)(q26;q22).
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.23128
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Internal tandem duplication of FLT3 in relapsed acute myeloid leukemia: a comparative analysis of bone marrow samples from 108 adult patients at diagnosis and relapse
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.23128
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Acute myelogenous leukemia with internal tandem duplication of the Flt3 gene appearing or altering at the time of relapse: a report of two cases.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.23128
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Studies of FLT3 mutations in paired presentation and relapse samples from patients with acute myeloid leukemia: implications for the role of FLT3 mutations in leukemogenesis, minimal residual disease detection, and possible therapy with FLT3 inhibit
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.23128
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Molecular evolution of acute myeloid leukaemia in relapse: unstable N-ras and FLT3 genes compared with p53 gene.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.23128
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prognostic value of minimal residual disease quantification by real-time reverse transcriptase polymerase chain reaction in patients with core binding factor leukemias
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.23128
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Molecular monitoring of acute myeloid leukemia associated with inv(16): threshold of CBFbeta/MYH11 transcript copy number above which relapse occurs and below which continuous Complete Remission is likely.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1002%2FCNCR.23128
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1002/CNCR.23128
1 reference
stated in
Europe PubMed Central
PubMed publication ID
18000811
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18000811%20AND%20SRC:MED&resulttype=core&format=json
retrieved
26 December 2019
PubMed publication ID
18000811
1 reference
stated in
Europe PubMed Central
PubMed publication ID
18000811
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18000811%20AND%20SRC:MED&resulttype=core&format=json
retrieved
26 December 2019
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit